Blood test for early Alzheimer's detection in primary care
Part of Brain & nervous system, Mental health clinical trials.
This study is looking for a simple blood test to help diagnose Alzheimer's disease earlier and more accurately in a primary care setting. If you are 55 or older with memory concerns, participating could help improve diagnostic methods and may lead to earlier support and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 55 years of age or older
- Have concerns about memory or thinking (or a family member/partner has these concerns)
- Be able to give consent, and be fluent in English with adequate vision and hearing for cognitive tests
- Must not have a prior diagnosis of Alzheimer's or related dementia
- Must not have brain abnormalities like tumors or significant vascular malformations on MRI (if done), and must not have had a recent stroke within 12 months
- Must be able to undergo a lumbar puncture (spinal tap) safely
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple blood draw can help spot early signs of Alzheimer's disease. It aims to include people from diverse backgrounds who do not currently have memory problems, which may help make early detection more accessible for everyone.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
This study looks at a specific brain pathway that may be linked to early memory loss in Alzheimer's disease. It compares people with early Alzheimer's to healthy older adults to understand how connections between brain cells start to break down.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study looks at blood tests to help diagnose and track brain diseases (like Alzheimer's) or mental health conditions. It compares patients to healthy volunteers to find better ways to detect and monitor these illnesses.
Hear when a new Biomarkers / Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.